Vaccinex Inc Revenue Growth Rates (VCNX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Vaccinex Inc   (NONE: VCNX)
 

VCNX's Revenue Growth by Quarter and Year

Vaccinex Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VCNX Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December 0.20
3rd Quarter September -1.05
2nd Quarter June 0.15
1st Quarter March 0.10
FY -0.60

VCNXs Annual Revenue
Vaccinex Inc 's Revenue in the fiscal year 2024 $ -0.60 millions
Vaccinex Inc 's Revenue in the fiscal year 2023 $ 0.57 millions
Vaccinex Inc 's Revenue in the fiscal year 2022 $ 0.28 millions
Vaccinex Inc 's Revenue in the fiscal year 2021 $ 0.90 millions
Vaccinex Inc 's Revenue in the fiscal year 2020 $ 0.63 millions




VCNX Revenue fourth quarter 2024 Y/Y Growth Comment
Vaccinex Inc in the fourth quarter 2024 achieved Revenue of $ 0.20 millions compare to recorded in same quarter a year ago.

According to the results reported in the fourth quarter 2024, Vaccinex Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Vaccinex Inc ' s Revenue no change of 0% ranks overall at the positon no. in the fourth quarter 2024.


VCNX Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - - - -
3rd Quarter September - -60 % 0 % -92.06 %
2nd Quarter June - - - -
1st Quarter March -81.82 % - - -
FY   - 103.57 % -68.89 % -

Financial Statements
Vaccinex Inc 's fourth quarter 2024 Revenue $ 0.20 millions VCNX's Income Statement
Vaccinex Inc 's fourth quarter 2023 Revenue $ 0.00 millions Quarterly VCNX's Income Statement


VCNX Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December - - 360 % -
3rd Quarter September - - - -
2nd Quarter June 50 % - - -
1st Quarter March - 139.13 % - -
FY (Year on Year)   - 103.57 % -68.89 % -


Back to VCNX Growth rate Comparisons >> Back to VCNX Growth rate Comparisons >>


Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Vaccinex Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


VCNX's IV. Quarter Q/Q Revenue Comment
Improvement IV. Quarter 2024where Vaccinex Inc published Revenue of $ 0.20 millions should is starting point of positive performance.Vaccinex Inc announced in the IV. Quarter 2024 Revenue of $ 0.20 millions compare to recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Vaccinex Inc achieved highest sequential Revenue growth. While Vaccinex Inc 's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


VCNX's IV. Quarter Q/Q Revenue Comment
Improvement IV. Quarter 2024where Vaccinex Inc published Revenue of $ 0.20 millions should is starting point of positive performance.Vaccinex Inc announced in the IV. Quarter 2024 Revenue of $ 0.20 millions compare to recorded in previos quarter.

Within Major Pharmaceutical Preparations industry Vaccinex Inc achieved highest sequential Revenue growth. While Vaccinex Inc 's Revenue growth quarter on quarter, overall rank is .


Vaccinex Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)
Cumulative Revenue 12 Months Ending $ -0.60 $ -0.78 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
Vaccinex Inc ' has realized cumulative trailing twelve months of $ -1 millions in the Dec 31 2024 period.
The business is worsening as the cumulative is inflating from $ 0 millions for the period from Sep 30 2024 to Dec 31 2023 and $ millions from the TTM period ending Dec 31 2023.

Vaccinex Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
Vaccinex Inc ' has realized cumulative trailing twelve months of $ -1 millions in the Dec 31 2024 period.
The business is worsening as the cumulative is inflating from $ 0 millions for the period from Sep 30 2024 to Dec 31 2023 and $ millions from the TTM period ending Dec 31 2023.

Vaccinex Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
VCNX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2024
Adapthealth Corp -0.19%$ -0.185 millions
Bioaffinity Technologies Inc -0.26%$ -0.260 millions
Organon and Co -0.38%$ -0.375 millions
Royalty Pharma Plc-0.41%$ -0.407 millions
Carlisle Companies Incorporated-0.41%$ -0.408 millions
Silo Pharma Inc-0.41%$ -0.409 millions
Shl Telemedicine Ltd-0.52%$ -0.519 millions
Cytek Biosciences Inc -0.59%$ -0.586 millions
Kronos Bio Inc -0.70%$ -0.700 millions
Koninklijke Philips Nv-0.81%$ -0.815 millions
Enhabit Inc -0.92%$ -0.921 millions
Charles River Laboratories International inc -1.08%$ -1.078 millions
Elanco Animal Health Incorporated-1.45%$ -1.449 millions
Illumina Inc -1.60%$ -1.604 millions
Perrigo Company Plc-1.62%$ -1.616 millions
Fonar Corporation-1.72%$ -1.717 millions
Quipt Home Medical Corp -1.90%$ -1.905 millions
Bio rad Laboratories Inc -1.91%$ -1.910 millions
Surmodics Inc -2.06%$ -2.062 millions
Avantor Inc -2.10%$ -2.101 millions
Petvivo Holdings Inc -2.11%$ -2.111 millions
Iridex Corp-2.15%$ -2.153 millions
Assertio Holdings inc -2.43%$ -2.431 millions
Apyx Medical Corp-2.58%$ -2.578 millions
Bioxcel Therapeutics Inc -2.66%$ -2.660 millions
Zynex inc -2.66%$ -2.665 millions
Nrc Health-2.88%$ -2.879 millions
Teladoc Health Inc -3.03%$ -3.033 millions
Orchestra Biomed Holdings Inc -3.44%$ -3.435 millions
Xenetic Biosciences Inc -3.45%$ -3.449 millions


About Vaccinex Inc Revenue Growth Rates (VCNX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Vaccinex Inc (CIK 1205922).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000950170-25-054318
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Vaccinex Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.